Viewing Study NCT03390595


Ignite Creation Date: 2025-12-24 @ 1:50 PM
Ignite Modification Date: 2026-01-01 @ 6:17 PM
Study NCT ID: NCT03390595
Status: COMPLETED
Last Update Posted: 2023-10-18
First Post: 2017-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma
Sponsor: Associació per a la Recerca Oncologica, Spain
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module